Pharmacokinetics of colchicine in human plasma and leukocytes

Pharmacokinetics of colchicine in human plasma and leukocytes - PK study of colchicine

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019907

Enrollment

Registered

2015-11-26

Start date

2015-01-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

Oral colchicine at 0.25mg or 0.5mg per day for 1 days or seven days

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy males aged 20 to 40 years old

Exclusion criteria

Exclusion criteria: Subjects with any abnormal findings in physical examinations and laboratory tests. Subjects on any chronicmedication

Design outcomes

Primary

Measure	Time frame
Concentrations of colchicine in plasma and leukocytes after the single and multiple doses	—

Countries

Japan

Contacts

Public ContactShinichiro Ueda

University of The Ryukyus Department of Clinical Pharmacology and Therapeutics

blessyou@med.u-ryukyu.ac.jp0988951195

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026